U
Reliq Health Technologies Inc. RHTH.V
TSX
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2023 12/31/2022 09/30/2022 06/30/2022 03/31/2022
Net Income 94.87% 82.72% 69.65% 29.39% 12.77%
Total Depreciation and Amortization -9.15% -6.82% -8.27% -7.70% 33,633.33%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -90.94% -96.25% -73.75% 31.08% 7.62%
Change in Net Operating Assets -49.48% -22.61% -98.96% -2,744.42% -1,672.17%
Cash from Operations 21.93% 22.06% 14.71% -14.04% -37.81%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- -100.00%
Cash from Investing -- -- -- -- 100.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 39.75% 35.66% 31.74% 18.99% -37.34%
Issuance of Common Stock -25.81% -19.66% -39.20% 7.46% 26.59%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -238.86% -- -- -- 164.49%
Cash from Financing -32.34% -22.43% -39.15% 10.33% 36.16%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -200.00% -- --
Net Change in Cash -272.71% 14.27% -199.07% -147.72% 193.55%
Weiss Ratings